Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 2, 1999

View Archived Issues

Pharmacokinetic and efficacy studies reported for novel prostate cancer drug

NuOncology Labs awarded U.S. patent for anticancer compounds

Sepracor: Q2 1999 highlights

Anti-VEGF enhances efficacy of radiation therapy

A review of SSRI-induced female sexual dysfunction and treatment strategies

Structural Bioinformatics and BioChem Pharma enter second drug discovery collaboration

Positive results achieved in primate studies of Titan's Spheramine

Cyberonics receives expedited review status for depression therapy

Aviron and Medeva extend FluMist collaboration

Matritech seeks expanded use for bladder cancer diagnostic

Allergan's second quarter highlights characterized by new agreements

Vertex' neurophilin ligands show neuroprotective effect in models of Parkinson's disease

New apoptosis inducers claimed by Takara Shuzo

Novel selectin inhibitors revealed in the patent literature by Sumitomo

Taisho, Nihon Nohyaku continue research into MDR ligands

Novel antifungal agents, chymase inhibitors isolated by Shionogi

U.S. patent provides protection for Cyclacel's Penetratin drug delivery technology

ThromboSol to be studied in chemotherapy recipients at M.D. Anderson

Vitex, Pentose announce merger agreement

BP-897, a partial dopamine D3 receptor agonist with potential in treating cocaine dependency

Solimastat is a potent MMP inhibitor with significant advantages over related compounds

Brazilian trial of Biotech Holdings' diabetes drug completed

Mutual recognition granted to Agrippal; vaccine to be marketed throughout Europe

OSI grants nonexclusive license for gene transcription patents to Pharmacia & Upjohn

Pharmacia & Upjohn receives approvable letter from FDA for Vestra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...